Dr. Ashe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St Se
Mmc 295
Minneapolis, MN 55455Phone+1 612-626-0652
Education & Training
- Harvard Medical SchoolClass of 1982
Certifications & Licensure
- MN State Medical License 1992 - 2022
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2009
Publications & Presentations
PubMed
- 267 citationsApolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.David M. Holtzman, Anne M. Fagan, Brian Mackey, Tanya Tenkova, Leah J. Sartorius
Annals of Neurology. 2000-06-01 - 831 citationsAge-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's DiseaseTakeshi Kawarabayashi, Linda H. Younkin, Takaomi C. Saido, Mikio Shoji, Karen H. Ashe
The Journal of Neuroscience. 2001-01-15 - 27 citationsA soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patientsPeng Liu, Benjamin Smith, Eric S. Huang, Abhishek Mahesh, Jean Paul G. Vonsattel
Acta Neuropathologica Communications. 2019-07-30
Press Mentions
- University of Minnesota Researcher Tries to Back up Alzheimer’s Findings Amid Image ScandalJuly 31st, 2022
- Was Alzheimer's Research Set Back by Doctored Information in a 'Groundbreaking' Study?July 25th, 2022
- Critical Elements of Leading Alzheimer’s Study Possibly FraudulentJuly 23rd, 2022
- Join now to see all
Grant Support
- Mechanisms Of Memory Loss Caused By The Beta-Amyloid MoleculeNational Institute Of Neurological Disorders And Stroke2009–2011
- In Search Of The Molecular Basis Of Memory Loss In TauopathyNational Institute Of Neurological Disorders And Stroke2008–2011
- Specific Amyloid-Beta Oligomer AptamersNational Institute On Aging2009–2010
- The Biology Of Alzheimer'S Disease In Transgenic MiceNational Institute On Aging2004–2008
- The Beta-Amyloid Molecule In Learning And MemoryNational Institute Of Neurological Disorders And Stroke2004–2008
- Modulating Cognitive Function In TG2576 Mice Modeling ADNational Institute Of Mental Health2002–2006
- Biology Of Alzheimers Disease In Transgenic MiceNational Institute On Aging2000–2004
- Dissecting Pathogenic Domains Of APP In Transgenic MiceNational Institute Of Neurological Disorders And Stroke1999–2003
- Genetic Manipulation Of Age Dependent Traits In Transgenic Mice Expressing APPNational Institute On Aging1999–2002
- The Biology Of Alzheimers Disease In Transgenic MiceNational Institute On Aging1999
- Toward A Model Of Alzheimers DiseaseNational Institute Of Neurological Disorders And Stroke1994–1998
- Molecular Pathophysiology Of PRP And APP MutantsNational Institute On Aging1995–1997
- Prion Protein Mutations In Inherited Prion DiseasesNational Institute Of Neurological Disorders And Stroke1992–1994
- Prion Protein Mutations In Inherited Prion DiseasesNational Institute Of Neurological Disorders And Stroke1990–1992
- Genetics Of The Human Prion Protein GeneNational Institute Of General Medical Sciences1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: